World Model · podcast knowledge graph

#23 - Tom Dayspring, M.D., FACP, FNLA – Part IV of V: Statins, ezetimibe, PCSK9 inhibitors, niacin, cholesterol and the brain

2018-10-18 · 120 min · episode 23 · 10 entities

episode page audio

Asserted relationships

  • → hosted by Peter Attia, MD person
    0.55
    evidence rules-v4
    Feed author/publisher: Peter Attia, MD
  • → discusses Health & Fitness concept
    0.40
    evidence rules-v4
    Feed category: Health & Fitness
  • → discusses Medicine concept
    0.40
    evidence rules-v4
    Feed category: Medicine
  • → discusses Fitness concept
    0.40
    evidence rules-v4
    Feed category: Fitness

Entities found in this episode

concepts 8

  • mentioned Health & Fitness concept
    0.50
    evidence rules-v4
    Feed category: Health & Fitness
  • mentioned Medicine concept
    0.50
    evidence rules-v4
    Feed category: Medicine
  • mentioned Fitness concept
    0.50
    evidence rules-v4
    Feed category: Fitness
  • discusses Health & Fitness concept
    0.40
    evidence rules-v4
    Feed category: Health & Fitness
  • discusses Medicine concept
    0.40
    evidence rules-v4
    Feed category: Medicine
  • discusses Fitness concept
    0.40
    evidence rules-v4
    Feed category: Fitness
  • mentioned FACP concept
    0.35
    evidence rules-v4
    FACP
  • mentioned FNLA concept
    0.35
    evidence rules-v4
    FNLA

persons 2

  • mentioned Peter Attia, MD person
    0.70
    evidence rules-v4
    Feed author/publisher: Peter Attia, MD
  • hosted by Peter Attia, MD person
    0.55
    evidence rules-v4
    Feed author/publisher: Peter Attia, MD
Episode description as stored
In this five-part series, Thomas Dayspring, M.D., FACP, FNLA, a world-renowned expert in lipidology, and one of Peter's most important clinical mentors, shares his wealth of knowledge on the subject of lipids. In Part IV, Peter and Tom review the history and current use of drugs to prevent cardiovascular disease. They also discuss why some drugs appear to be more effective than others, an in-depth conversation about niacin, cholesterol and brain health, and the futility of using CKs (creatinine kinase) and liver function tests to identify adverse effects in statins, to name a few topics in this episode. We discuss: Bile acid sequestrants and statins [ 2:00 ]; Ezetimibe (Zetia) [ 15:00 ]; PCSK9 inhibitors [27:30]; Fibrates [41:00]; Fish oil, DHA, and EPA [ 1:01:00 ]; Niacin [1:05:15]; PCSK9 inhibitors [1:23:45]; Cholesterol, statins, and the brain [ 1:30:00 ]; Elevated creatine kinase (CK) and liver function tests (LFTs) on statins [1:50:30]; and More. Learn more at  www.PeterAttiaMD.com Connect with Peter on Facebook | Twitter | Instagram .